Engaged in advancing innovative solutions for large-scale market applications
OMER, Israel, July 26, 2021 – Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced its board of directors authorized the company to take actions to promote a $2 million buyback program for the company’s ADRs. The company expects to formally approve the buyback in conjunction with the approval of its financial statements for the 6 months ended June 30, 2021, and based on a financial advisor’s opinion to be obtained. The company is required to file a motion seeking a court approval for the buyback program, and the effectiveness of the buyback plan, if formally approved, will be contingent upon such court’s approval.
Medigus Ltd. is a technology-based company engaged in advancing innovative solutions for large-scale market applications. To learn more about Medigus’ advanced technology, please visit www.medigus.com.